APOA1 and renal carcinoma: It should be noticed, that apoA-I is yet unfavorable marker of renal cancer, but some polymorphisms credibly increase the risk of renal carcinoma and enhance distal malignancy, which might be of special interest due to such polymorphisms, assumingly, may cause non-specific PTMs localization [58].